Knockdown of ST3GAL6 was observed to attenuate cell trans-endothelial migration ability, while elevation of ST3GAL6 expression was found to be associated with low overall survival in multiple myeloma patients [81] (Table 1). This evidence concerns the gene ST3GAL6 and plasma cell myeloma.